Creative Planning Obs Eva Sa Transaction History

Creative Planning

  • $101 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021
SELL
$2.56 - $3.35 $63,897 - $83,616
-24,960 Closed
0 $0
Q1 2021

Apr 30, 2021
BUY
$2.01 - $5.05 $50,169 - $126,048
24,960 New
24,960 $81,000

Others Institutions Holding OBSV

# of Institutions
2
Shares Held
88K
Call Options Held
0
Put Options Held
0
View Full List

About ObsEva SA

OBSV Quotes by TradingView
  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email